Transforming Pharmaceutical Operations: Sanofi's AI-Powered Manufacturing and Quality Excellence

Inna Ben-Anat, Sanofi, Philadelphia, US

Sanofi is pioneering the pharmaceutical industry's transformation into an AI-powered biopharma company, revolutionizing both manufacturing processes and quality management. This presentation showcases innovative AI implementations delivering measurable impact across operations.

Manufacturing Innovation: SimplY optimizes production yields through data-driven analysis of raw materials, equipment parameters, and historical batch data, enabling manufacturing scientists to identify actionable levers for improvement. This AI-powered approach addresses the inherent variability in biopharmaceutical processes, maximizing throughput and efficiency.

Quality Transformation: Moving from reactive to predictive quality practices, Sanofi has deployed AI-powered tools including Quality Maturity Index (QMI), Complaints by AI, and Deviations by AI. QMI provides real-time, digitalized assessment of quality maturity across sites, replacing manual evaluations.

Sanofi's responsible AI approach maintains human oversight in critical decisions while leveraging AI's analytical power, fostering a data-driven culture that enhances operational efficiency, regulatory compliance, and ultimately, patient care.

---

Short Biography of Presenting Author

Inna Ben-Anat is the Global Head of Smart Factories at Sanofi Manufacturing and Supply. In this role, Inna defines the vision and roadmap for Smart Factories, partnering with Digital and Business Units to achieve best-in-class performance through smart and sustainable manufacturing and digitization. Leveraging advanced technologies and AI throughout simplified and standardized industrial processes enables affordability and robustness of medicines and vaccines supply for the patients.

Previously, Inna served as the Head of Global Manufacturing Strategies and Technologies at Amgen. Before that, Inna was the Global QMS Technology Transfer and Commercialization Head at Merck, following 11 years at Teva in various leadership roles, including Head of the MS&T organization within the Americas operation, Head of Product Robustness, and Global QBD Strategy.

Inna holds an M.Sc. in Quality Assurance and Reliability and a B.Sc. in Chemical Engineering.